Medscape Medical News, January 10, 2025 SABCS 2024 CDK 4/6 Blocker Prolongs Survival in HER2+ Breast Cancer “Incredible” results from the PATINA trial suggested a new standard of care for HER2 ...

SABCS 2024 PATINA Trial Shifts Paradigm in HER2+/ER+ Breast Cancer Dr Kathy Miller discusses how the PATINA trial reshapes treatment strategies for HER2+/ER+ breast cancer patients.

Over the course of 32 years, local gift store chain Patina has survived copycats, fires, riots, a pandemic, and Amazon. And now, founders Rick Haase and Christine Ward have ensured their popular ...

Healthcare giant Pfizer’s IBRANCE (palbociclib) as a combination therapy has improved progression-free survival from a Phase III trial in patients with metastatic breast cancer. Unveiled ...